Neurimmune today announced that it has expanded on its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, AstraZeneca Rare Disease by entering into an exclusive global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback